CD169 is a marker for highly pathogenic phagocytes in multiple sclerosis

Abstract

Our findings indicate that CD169⁺ cells promote neuroinflammation. Furthermore, they suggest that CD169⁺ phagocytes play a key role in the pathophysiology of MS. Hence, targeting CD169⁺ phagocytes may hold therapeutic value for MS.